Limburg Ventures is the predecessor fund of Chemelot Ventures. It was set up in 2004 and made 22 investments. The active investment period is over. New investments are done via Chemelot Ventures. Below you will find an overview of the most relevant facts regarding Limburg Ventures:
|Legal Name||Limburg Ventures B.V.|
|Legal form||Dutch private limited liability company|
|Founders||DSM Nederland B.V.
NV Industriebank LIOF
|Life, size||Closed-end fund, € 15 Million|
|Philosophy||Enhance value of portfolio companies by using the Fund’s network in the region and at the Chemelot Campus|
|Investment focus by sector||Life sciences, advance materials.
In life sciences the fund focuses on regenerative medicine, drug delivery, drug screening and formulation and diagnostics. In advanced materials the focus is on (bio-based) polymers and coatings; processing and applications.
|Investment focus by stage||Early stage (in principle, past the ‘seed’ phase)|
|Investment focus by geography||Dutch Province of Limburg and Meuse-Rhine Euregion|
The fund is managed by Chemelot Ventures Management BV.
For an overview of Limburg Ventures’ active portfolio companies click here and scroll down.